Peptichemio in pretreated patients with plasmacell neoplasms
- 1 September 1986
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 22 (9) , 1053-1058
- https://doi.org/10.1016/0277-5379(86)90005-2
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Treatment of multiple myeloma with M-2 protocol and without maintenance therapyEuropean Journal of Cancer and Clinical Oncology, 1983
- Cross-resistance to alkylating agents in multiple myelomaCancer, 1983
- Hexamethylmelamine and prednisone in the treatment of refractory multiple myelomaAmerican Journal of Clinical Oncology, 1982
- Vindesine therapy in melphalan-resistant multiple myelomaPublished by Elsevier ,1981
- A phase II study of peptichemio in advanced breast cancerCancer, 1980
- Multiple myeloma: quantitative staging and assessment of response with a programmable pocket calculatorBlood, 1977
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Melphalan and prednisone: An effective combination for the treatment of multiple myelomaThe American Journal of Medicine, 1973
- Treatment for Multiple MyelomaJAMA, 1969